AU3193884A - Immunomodulating medicaments of balterio phagic lyses of two or more bacteria - Google Patents

Immunomodulating medicaments of balterio phagic lyses of two or more bacteria

Info

Publication number
AU3193884A
AU3193884A AU31938/84A AU3193884A AU3193884A AU 3193884 A AU3193884 A AU 3193884A AU 31938/84 A AU31938/84 A AU 31938/84A AU 3193884 A AU3193884 A AU 3193884A AU 3193884 A AU3193884 A AU 3193884A
Authority
AU
Australia
Prior art keywords
bacteria
immunomodulating
balterio
phagic
lyses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU31938/84A
Other versions
AU564652B2 (en
Inventor
Yves-Marie Page
Christine Vanderhoven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Publication of AU3193884A publication Critical patent/AU3193884A/en
Application granted granted Critical
Publication of AU564652B2 publication Critical patent/AU564652B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1. Immunomodulating medicament of biological origin, of which the active principle is formed by the products of lysis or a fraction of these products of bacteria lysed by bacteriophagic route, characterised in that it contains, as active principle, the sterile lysis filtrate of at least two bacteria lysed by homologous bacteriophagic route ; the bacteria chosen being Klebsiella pneumoniae and Escherichia coli.
AU31938/84A 1983-08-17 1984-08-15 Immunomodulating medicaments of balterio phagic lyses of two or more bacteria Ceased AU564652B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8313362A FR2550707B1 (en) 1983-08-17 1983-08-17 IMMUNOMODULATOR OF BIOLOGICAL MEDICINE AND PROCESS FOR PREPARING THE SAME
FR8313362 1983-08-17

Publications (2)

Publication Number Publication Date
AU3193884A true AU3193884A (en) 1985-02-21
AU564652B2 AU564652B2 (en) 1987-08-20

Family

ID=9291646

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31938/84A Ceased AU564652B2 (en) 1983-08-17 1984-08-15 Immunomodulating medicaments of balterio phagic lyses of two or more bacteria

Country Status (22)

Country Link
EP (1) EP0139551B1 (en)
JP (1) JPS6069022A (en)
AT (1) ATE36240T1 (en)
AU (1) AU564652B2 (en)
CA (1) CA1229566A (en)
CS (1) CS270410B2 (en)
DD (1) DD232432A5 (en)
DE (1) DE3473228D1 (en)
DK (1) DK160807C (en)
ES (1) ES535213A0 (en)
FR (1) FR2550707B1 (en)
HU (1) HU193217B (en)
IL (1) IL72589A (en)
IN (1) IN161616B (en)
MA (1) MA20203A1 (en)
NO (1) NO843274L (en)
NZ (1) NZ209171A (en)
OA (1) OA07794A (en)
PT (1) PT79090B (en)
SU (1) SU1487815A3 (en)
YU (1) YU143284A (en)
ZA (1) ZA846151B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
FR2620130B1 (en) * 1987-09-08 1990-01-12 Lipha NOVEL WATER-SOLUBLE POLYSACCHARIDES, PROCESS FOR OBTAINING THEM, USE THEREOF AS MEDICAMENTS AND PREPARATION CONTAINING THEM
IL88480A0 (en) * 1987-11-27 1989-06-30 Univ Toronto Proteinaceous compositions
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
EP1487273B1 (en) 2002-02-13 2009-01-21 Immunology Laboratories, Inc. Compositions and methods for treatment of microbial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758977A (en) * 1969-11-17 1971-05-17 Glaxo Lab Ltd BIOCHEMICAL PROCESS
CH633188A5 (en) * 1978-05-26 1982-11-30 Om Laboratoires Sa MEDICINE FOR INFECTIOUS DISEASES OF THE RESPIRATORY TRACT.
CH639852A5 (en) * 1979-07-26 1983-12-15 Om Laboratoires Sa MEDICINE AGAINST INFECTIOUS DISEASES OF THE URINARY AND DIGESTIVE PATHWAYS.
US4322405A (en) * 1981-04-06 1982-03-30 Laboratoires Om Societe Anonyme Method for treating rheumatoid arthritis

Also Published As

Publication number Publication date
DK393884A (en) 1985-02-18
DE3473228D1 (en) 1988-09-15
IL72589A (en) 1988-01-31
ATE36240T1 (en) 1988-08-15
NO843274L (en) 1985-02-18
PT79090A (en) 1984-09-01
DD232432A5 (en) 1986-01-29
PT79090B (en) 1986-08-14
ZA846151B (en) 1985-03-27
DK393884D0 (en) 1984-08-16
EP0139551A2 (en) 1985-05-02
FR2550707B1 (en) 1986-02-28
NZ209171A (en) 1988-10-28
CS270410B2 (en) 1990-06-13
EP0139551A3 (en) 1985-07-10
HUT35013A (en) 1985-05-28
SU1487815A3 (en) 1989-06-15
IN161616B (en) 1988-01-02
ES8602415A1 (en) 1985-12-01
FR2550707A1 (en) 1985-02-22
YU143284A (en) 1991-02-28
IL72589A0 (en) 1984-11-30
HU193217B (en) 1987-08-28
EP0139551B1 (en) 1988-08-10
MA20203A1 (en) 1985-04-01
CS592184A2 (en) 1989-11-14
ES535213A0 (en) 1985-12-01
DK160807B (en) 1991-04-22
AU564652B2 (en) 1987-08-20
OA07794A (en) 1986-11-20
CA1229566A (en) 1987-11-24
JPS6069022A (en) 1985-04-19
DK160807C (en) 1991-10-07

Similar Documents

Publication Publication Date Title
EP0225608A3 (en) Medicine
WO1989006649A3 (en) Antibacterial agents
AU3438284A (en) Sucralfat-suspension
GR3003937T3 (en)
AU7687987A (en) Starch-free yoghurt product
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU564652B2 (en) Immunomodulating medicaments of balterio phagic lyses of two or more bacteria
AU4016089A (en) The expression of homologous and heterologous proteins, which are able to function, on the outer membrane of e. coli and other gram-negative bacteria
AU2170892A (en) Concentrated sterile milk product
AU1174588A (en) Anticonvulsant agents
MC1977A1 (en) PROCESS FOR THE PREPARATION OF AN INHIBITOR OR DESTRUCTIVE COMPOSITION OF AT LEAST ONE SINGLE-CELL LIVING BEING CONTAINING FLUOR F AND LITHIUM LI +
AU1860488A (en) Agent for inactivating spores and process for prolonging the storage life of products, substances or produce which can be spoiled by bacterial spore infestation
AU664101B2 (en) Novel phospholipid derivatives
ES8104402A1 (en) Bacterial lysates
NZ218227A (en) Cephalosporin derivatives and pharmaceutical compositions
Brisou et al. Use of microorganisms labelled with super (32) P for study of adherence.).
FR2581507B1 (en) PROCESS AND PRODUCTS FOR THE FIGHT AGAINST THE PYRALE OF THE VINE, SPARGANOTHIS PILLERIANA
IT8522237V0 (en) CONVEYOR FOR PRODUCTS SUCH AS COOKIES OR SIMILAR, WITH ANTI-BULKING DEVICE.